Clinical trials
Not yet recruiting Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 15 |
| 2025 | 31 |
| 2026 | 81 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 144 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 14 |
| Xuzhou Medical University | 5 |
| Assiut University | 4 |
| Odense University Hospital | 4 |
| The First Affiliated Hospital with Nanjing Medical University | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| CARsgen Therapeutics Co., Ltd. | 3 |
| GlaxoSmithKline | 3 |
| Peking Union Medical College Hospital | 3 |
| Qilu Pharmaceutical Co., Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 144 |
| Recurrence | 14 |
| Lymphoma | 11 |
| Neoplasms | 11 |
| Neoplasm, Residual | 6 |
| Hematologic Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Neoplasms, Plasma Cell | 4 |
| Leukemia | 3 |
| Lymphoma, B-Cell | 3 |
Trials
Showing 51 to 75 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.